Maria Ilenia De Bartolo, Daniele Belvisi, Romina Mancinelli, Matteo Costanzo, Claudia Caturano, Giorgio Leodori, Alfredo Berardelli, Giovanni Fabbrini, Giorgio Vivacqua
The search for reliable and easily accessible biomarkers in Parkinson's disease is receiving a growing emphasis, to detect neurodegeneration from the prodromal phase and to enforce disease-modifying therapies. Despite the need for non-invasively accessible biomarkers, the majority of the studies have pointed to cerebrospinal fluid or peripheral biopsies biomarkers, which require invasive collection procedures. Saliva represents an easily accessible biofluid and an incredibly wide source of molecular biomarkers...
December 1, 2024: Neural Regeneration Research